Chlamydia pneumoniae Infection in Mice Induces Chronic Lung Inflammation, iBALT Formation, and Fibrosis

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Jupelli, Madhulika ^a,d   Shimada, Kenichi ^a   Chiba, Norika ^a   Slepenkin, Anatoly ^b   Alsabeh, Randa ^c   Jones, Heather D ^a   Peterson, Ellena ^b   Chen, Shuang ^a   Arditi, Moshe ^a   Crother, Timothy R ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; BACTERIAL COUNT; C57BL 6 MOUSE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHLAMYDIAL PNEUMONIA; CHRONIC INFLAMMATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; FOLLICULAR DENDRITIC CELL; INDUCIBLE BRONCHUS ASSOCIATED LYMPHOID TISSUE; LUNG FIBROSIS; LYMPHOID TISSUE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; BACTERIAL LOAD; CELL COUNT; CHLAMYDIA INFECTIONS; CHLAMYDIAL PNEUMONIA; CHLAMYDOPHILA PNEUMONIAE; CHRONIC DISEASE; CYTOKINES; DENDRITIC CELLS; FIBROSIS; LUNG; MACROPHAGES; MICE; MICE, INBRED C57BL; T-LYMPHOCYTES;

EID: 84886385568     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0077447     Document Type: Article

References (57)

1. Kuo C-C, Jackson LA, Campbell LA, Grayston JT, (1995) Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8: 451-461.
2. Teh B, Grayson ML, Johnson PDR, Charles PGP, (2012) Doxycycline vs. macrolides in combination therapy for treatment of community-acquired pneumonia. Clin Microbiol Infect 18: E71-E73 doi:10.1111/j.1469-0691.2011.03759.x.
3. Sutherland ER, Martin RJ, (2007) Asthma and atypical bacterial infection. Chest 132: 1962-1966 doi:10.1378/chest.06-2415.
4. Blasi F, Aliberti S, Allegra L, Piatti G, Tarsia P, et al. (2007) Chlamydophila pneumoniae induces a sustained airway hyperresponsiveness and inflammation in mice. Respir Res 8: 83 doi:10.1186/1465-9921-8-83.
5. Johnston S, Martin R, (2005) Chlamydophila pneumoniae and Mycoplasma pneumoniae: a role in asthma pathogenesis? Am J Respir Crit Care Med 172: 1078-1089.
6. Blasi F, Damato S, Cosentini R, Tarsia P, Raccanelli R, et al. (2002) Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 57: 672-676.
7. Hahn D, Dodge R, Golubjatnikov R, (1991) Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. Jama 266: 225-230.
8. Webley W, Salva P, Andrzejewski C, Cirino F, West C, et al. (2005) The bronchial lavage of pediatric patients with asthma contains infectious Chlamydia. Am J Respir Crit Care Med 171: 1083-1088.
9. Watson C, Alp NJ, (2008) Role of Chlamydia pneumoniae in atherosclerosis. Clin Sci 114: 509-531 doi:10.1042/CS20070298.
10. Naiki Y, Sorrentino R, Wong MH, Michelsen KS, Shimada K, et al. (2008) TLR/MyD88 and liver X receptor alpha signaling pathways reciprocally control Chlamydia pneumoniae-induced acceleration of atherosclerosis. The Journal of Immunology 181: 7176-7185.
11. Shimada K, Chen S, Dempsey PW, Sorrentino R, Alsabeh R, et al. (2009) The NOD/RIP2 pathway is essential for host defenses against Chlamydophila pneumoniae lung infection. PLoS Pathog 5: e1000379 doi:10.1371/journal.ppat.1000379.
12. Hammerschlag MR, (2002) The intracellular life of chlamydiae. Semin Pediatr Infect Dis 13: 239-248 doi:10.1053/spid.2002.127201.
13. Yang ZP, Cummings PK, Patton DL, Kuo C-C, (1994) Ultrastructural lung pathology of experimental Chlamydia pneumoniae pneumonitis in mice. J INFECT DIS 170: 464-467.
14. Hogan RJ, Mathews SA, Mukhopadhyay S, Summersgill JT, Timms P, (2004) Chlamydial persistence: beyond the biphasic paradigm. Infect Immun 72: 1843-1855.
15. He X, Mekasha S, Mavrogiorgos N, Fitzgerald KA, Lien E, et al. (2010) Inflammation and fibrosis during Chlamydia pneumoniae infection is regulated by IL-1 and the NLRP3/ASC inflammasome. The Journal of Immunology 184: 5743-5754 doi:10.4049/jimmunol.0903937.
16. Foo SY, Phipps S, (2010) Regulation of inducible BALT formation and contribution to immunity and pathology. Mucosal Immunology 3-544 doi:10.1038/mi.2010.52.
17. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653 doi:10.1056/NEJMoa032158.
18. Ulrichs T, Kosmiadi GA, Trusov V, Jörg S, Pradl L, et al. (2004) Human tuberculous granulomas induce peripheral lymphoid follicle-like structures to orchestrate local host defence in the lung. The Journal of pathology 204: 217-228 doi:10.1002/path.1628.
19. Rangel-Moreno J, Hartson L, Navarro C, Gaxiola M, Selman M, et al. (2006) Inducible bronchus-associated lymphoid tissue (iBALT) in patients with pulmonary complications of rheumatoid arthritis. J Clin Invest 116: 3183-3194 doi:10.1172/JCI28756.
20. Yang ZP, Kuo C-C, Grayston JT, (1993) A mouse model of Chlamydia pneumoniae strain TWAR pneumonitis. Infect Immun 61: 2037-2040.
21. Kaukoranta-Tolvanen SS, Laurila AL, Saikku P, Leinonen M, Liesirova L, et al. (1993) Experimental infection of Chlamydia pneumoniae in mice. Microb Pathog 15: 293-302 doi:10.1006/mpat.1993.1079.
22. Crother TR, Ma J, Jupelli M, Chiba N, Chen S, et al. (2012) Plasmacytoid dendritic cells play a role for effective innate immune responses during Chlamydia pneumoniae infection in mice. PLoS ONE 7: e48655 doi:10.1371/journal.pone.0048655.
23. Lawrence T, Natoli G, (2011) Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 11: 750-761 doi:10.1038/nri3088.
24. Murray PJ, Wynn TA (2011) Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol. doi:10.1038/nri3073.
25. Duan M, Li WC, Vlahos R, Maxwell MJ, Anderson GP, et al. (2012) Distinct macrophage subpopulations characterize acute infection and chronic inflammatory lung disease. The Journal of Immunology 189: 946-955 doi:10.4049/jimmunol.1200660.
26. Qin H, Holdbrooks AT, Liu Y, Reynolds SL, Yanagisawa LL, et al. (2012) SOCS3 deficiency promotes M1 macrophage polarization and inflammation. The Journal of Immunology 189: 3439-3448 doi:10.4049/jimmunol.1201168.
27. Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, et al. (2012) Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. Circulation 125: 1234-1245 doi:10.1161/CIRCULATIONAHA.111.052126.
28. Rahat MA, Bitterman H, Lahat N, (2011) Molecular mechanisms regulating macrophage response to hypoxia. Front Immunol 2: 45 doi:10.3389/fimmu.2011.00045.
29. Gordon S, Martinez FO, (2010) Alternative activation of macrophages: mechanism and functions. Immunity 32: 593-604 doi:10.1016/j.immuni.2010.05.007.
30. Grayston JT, Wang SP, Kuo C-C, Campbell LA, (1989) Current knowledge on Chlamydia pneumoniae, strain TWAR, an important cause of pneumonia and other acute respiratory diseases. Eur J Clin Microbiol Infect Dis 8: 191-202.
31. Laurila AL, Hertzen Von L, Saikku P (1997) Chlamydia pneumoniae and chronic lung diseases. Scand J Infect Dis Suppl 104: 34-36.
32. Saikku P, Leinonen M, Mattila K, Ekman MR, Nieminen MS, et al. (1988) Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 2: 983-986.
33. Campbell LA, Kuo C-C, (2003) Chlamydia pneumoniae and atherosclerosis. Semin Respir Infect 18: 48-54 doi:10.1053/srin.2003.50006.
34. Kalayoglu MV, Libby P, Byrne GI, (2002) Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease. Jama 288: 2724-2731.
35. Littman AJ, Jackson LA, Vaughan TL, (2005) Chlamydia pneumoniae and lung cancer: epidemiologic evidence. Cancer Epidemiol Biomarkers Prev 14: 773-778 doi:10.1158/1055-9965.EPI-04-0599.
36. Grayston JT, (2000) Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J INFECT DIS 181Suppl 3: S402-S410 doi:10.1086/315596.
37. Anderson JL, Muhlestein JB, (2004) Antibiotic trials for coronary heart disease. Tex Heart Inst J 31: 33-38.
38. Galli SJ, Borregaard N, Wynn TA, (2011) Phenotypic and functional plasticity of cells of innate immunity: macrophages, mast cells and neutrophils. Nat Immunol 12: 1035-1044 doi:10.1038/ni.2109.
39. Malinverni R, Kuo C-C, Campbell LA, Grayston JT, (1995) Reactivation of Chlamydia pneumoniae lung infection in mice by cortisone. J INFECT DIS 172: 593-594.
40. Laitinen K, Laurila AL, Leinonen M, Saikku P, (1996) Reactivation of Chlamydia pneumoniae infection in mice by cortisone treatment. Infect Immun 64: 1488-1490.
41. Noble PW, Barkauskas CE, Jiang D, (2012) Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 122: 2756-2762 doi:10.1172/JCI60323.
42. Shah NR, Noble P, Jackson RM, King TE, Nathan SD, et al. (2005) A critical assessment of treatment options for idiopathic pulmonary fibrosis. Vol. 22: 167-174.
43. King TE, Pardo A, Selman M, (2011) Idiopathic pulmonary fibrosis. Lancet 378: 1949-1961 doi:10.1016/S0140-6736(11)60052-4.
44. Tighe RM, Liang J, Liu N, Jung Y, Jiang D, et al. (2011) Recruited exudative macrophages selectively produce CXCL10 after noninfectious lung injury. Am J Respir Cell Mol Biol 45: 781-788 doi:10.1165/rcmb.2010-0471OC.
45. Pechkovsky DV, Prasse A, Kollert F, Engel KMY, Dentler J, et al. (2010) Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction. Clin Immunol 137: 89-101 doi:10.1016/j.clim.2010.06.017.
46. Prasse A, Pechkovsky DV, Toews GB, Jungraithmayr W, Kollert F, et al. (2006) A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18. Am J Respir Crit Care Med 173: 781-792 doi:10.1164/rccm.200509-1518OC.
47. Wilson MS, Wynn TA, (2009) Pulmonary fibrosis: pathogenesis, etiology and regulation. Mucosal Immunology 2: 103-121 doi:10.1038/mi.2008.85.
48. Shearer JD, Richards JR, Mills CD, Caldwell MD, (1997) Differential regulation of macrophage arginine metabolism: a proposed role in wound healing. Am J Physiol 272: E181-E190.
49. Prasse A, Germann M, Pechkovsky DV, Markert A, Verres T, et al. (2007) IL-10-producing monocytes differentiate to alternatively activated macrophages and are increased in atopic patients. J Allergy Clin Immunol 119: 464-471 doi:10.1016/j.jaci.2006.09.030.
50. Mora AL, Torres-González E, Rojas M, Corredor C, Ritzenthaler J, et al. (2006) Activation of alveolar macrophages via the alternative pathway in herpesvirus-induced lung fibrosis. Am J Respir Cell Mol Biol 35: 466-473 doi:10.1165/rcmb.2006-0121OC.
51. Mi S, Li Z, Yang H-Z, Liu H, Wang J-P, et al. (2011) Blocking IL-17A Promotes the Resolution of Pulmonary Inflammation and Fibrosis Via TGF-{beta}1-Dependent and-Independent Mechanisms. The Journal of Immunology. doi:10.4049/jimmunol.1004081.
52. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, et al. (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A dependent. Journal of Experimental Medicine 207: 535-552 doi:10.1084/jem.20092121.
53. Rangel-Moreno J, Carragher DM, la Luz Garcia-Hernandez de M, Hwang JY, Kusser K, et al. (2011) The development of inducible bronchus-associated lymphoid tissue depends on IL-17. Nat Immunol 12: 639-646 doi:10.1038/ni.2053.
54. Gérard HC, Mishra MK, Mao G, Wang S, Hali M, et al. (2013) Dendrimer-enabled DNA delivery and transformation of Chlamydia pneumoniae. Nanomedicine. doi:10.1016/j.nano.2013.04.004.
55. Song L, Carlson JH, Whitmire WM, Kari L, Virtaneva K, et al. (2013) The Chlamydia trachomatis plasmid-encoded Pgp4 is a transcriptional regulator of virulence associated genes. Infect Immun. doi:10.1128/IAI.01305-12.
56. Schröder NWJ, Crother TR, Naiki Y, Chen S, Wong MH, et al. (2008) Innate immune responses during respiratory tract infection with a bacterial pathogen induce allergic airway sensitization. J Allergy Clin Immunol 122: 595-602.e595 doi:10.1016/j.jaci.2008.06.038.
57. Naiki Y, Michelsen KS, Schröder NWJ, Alsabeh R, Slepenkin A, et al. (2005) MyD88 is pivotal for the early inflammatory response and subsequent bacterial clearance and survival in a mouse model of Chlamydia pneumoniae pneumonia. J Biol Chem 280: 29242-29249 doi:10.1074/jbc.M503225200.